Related Experiment Videos
[Effectiveness of heparin in patients with acute myocardial infarction]
Insights
Heparin treatment for myocardial infarction patients led to fewer deaths and faster healing of ischemic lesions. Continuous intravenous heparin infusion offers significant advantages for acute myocardial infarction management.
Area of Science:
- Cardiology
- Pharmacology
- Critical Care Medicine
Context:
- Myocardial infarction (MI) management involves assessing treatment efficacy and complications.
- Heparin is a widely used anticoagulant, but its specific benefits in large-focal MI require detailed evaluation.
- Comparison with traditional treatments like polarizing mixtures is crucial for understanding therapeutic advancements.
Purpose:
- To compare the clinical outcomes and complications of heparin therapy versus a polarizing mixture in patients with large-focal myocardial infarction.
- To evaluate the impact of heparin on central hemodynamics, cardiac function, and tissue oxygenation.
- To assess the effect of heparin on the resolution of myocardial ischemia using precardiac charting.
Summary:
- A study involving 62 heparin-treated patients and 59 control patients with large-focal myocardial infarction (MI) demonstrated improved outcomes with heparin.
- Heparin treatment resulted in a lower mortality rate, improved central hemodynamics, enhanced cardiac contractility and pumping function, and better gaseous exchange.
- Precardiac charting indicated a more rapid reduction in ischemic lesion depth in the heparin group, highlighting the benefits of continuous intravenous heparin infusion.
Impact:
- Heparin therapy, particularly continuous intravenous infusion, offers significant advantages in managing acute myocardial infarction.
- Improved hemodynamic parameters and faster resolution of ischemia suggest a potential for reduced long-term morbidity.
- Findings support the optimization of heparin use in acute MI patients, potentially improving survival and recovery rates.
Abstract:
Clinical pattern and complications of the disease were studied in 62 heparin-treated patients with large-focal myocardial infarction as compared to a control group of 59 patients treated with a polarizing mixture of glucose, insulin, potassium, analgetics and tranquilizers. The changes of the necrotic area and lesion were assessed on the basis of precardiac charting. The results obtained were correlated to the data on central hemodynamics, heart contractility and pumping function, gaseous exchange and acid-base balance. Heparin-treated patients showed a smaller rate of fatal outcomes, although primary ventricular fibrillation and heart failure prevailed in the mortality pattern in both groups. Heparin treatment improved central hemodynamics, contractility and pumping function of the heart, and gaseous exchange, while prestress decreased simultaneously, which is the optimum effect for patients with acute myocardial infarction. Precardiac charting data showed heparin treatment to be associated with a more rapid reduction in the depth of the ischemic lesion. The advantages of continuous intravenous heparin infusion are demonstrated.